Search Results - "Gyldenkerne, C"

Causes of excess mortality in diabetes patients without coronary artery disease by Olesen, K, Gyldenkerne, C, Thrane, P G, Maeng, M

“…Abstract Background Diabetes (DM) patients without coronary artery disease (CAD) by coronary angiography have a similar risk of myocardial infarction and…”
Get full text

Microvascular complications, coronary artery disease and the risk of cardiovascular disease in diabetes patients undergoing coronary angiography: a cohort study from the Western Denmark Heart Registry by Olesen, K, Gyldenkerne, C, Thrane, P G, Maeng, M

“…Abstract Background Diabetes is associated with an increased risk of both microvascular macrovascular complications. The association between microvascular…”
Get full text

The impact of glycated hemoglobin A1c on cardiovascular risk in patients with and without coronary artery disease by Olesen, K K W, Thrane, P G, Hansen, M K, Gyldenkerne, C, Maeng, M

“…Abstract Background Diabetes is defined according to the level of glycated hemoglobin (HbA1c) based on the risk of microvascular complications. However, HbA1c…”
Get full text

Prevalence of SELECT-eligibility and incidence of 5-year major adverse cardiovascular outcomes in non-diabetic patients with myocardial infarction by Maeng, M, Gyldenkerne, C, Thrane, P, Hansen, M K, Olesen, K K W

“…Abstract Background The ongoing Semaglutide Effects on Heart Disease and Stroke in Patients with Overweight or Obesity (SELECT) trial has randomized 17,605…”
Get full text

Impact of glycated hemoglobin A1c on cardiovascular risk in diabetes patients with and without coronary artery disease by Olesen, K K W, Thrane, P G, Hansen, M K, Gyldenkerne, C, Maeng, M

“…Abstract Background Guidelines recommend a haemoglobin A1c (HbA1c) target <53 mmol/mol (7%) to achieve microvascular risk reduction. However, the impact of…”
Get full text

Fifteen-year follow-up and impact of age and sex on cardiovascular outcomes in diabetes and non-diabetes patients without CAD by Olesen, K K W, Thrane, P G, Hansen, M K, Gyldenkerne, C, Maeng, M

“…Abstract Background In the absence of angiographically-detectable coronary artery disease (CAD), patients with diabetes have a risk of myocardial infarction…”
Get full text

Diabetes, coronary artery disease, and risk of dementia – a cohort study from Western Denmark by Olesen, K.K.W, Thrane, P.G, Gyldenkerne, C, Thim, T, Maeng, M

“…Abstract Background Diabetes patients have a higher risk of both ischemic stroke and dementia compared to non-diabetes patients. Coronary artery disease (CAD)…”
Get full text

Risk of lower limb amputation in diabetes patients with and without coronary artery disease – a cohort study from Western Denmark by Olesen, K.K.W, Gyldenkerne, C, Thim, T, Thomsen, R.W, Maeng, M

“…Abstract Background Diabetes patients are at greater risk of lower limb amputation due to a higher risk of peripheral artery disease (PAD) and peripheral…”
Get full text

Microvascular disease, peripheral artery disease, and the risk of lower limb amputation by Olesen, K.K.W, Anand, S.S, Gyldenkerne, C, Thim, T, Maeng, M

“…Abstract Background Peripheral artery disease (PAD) is the leading cause of non-traumatic lower limb amputation. Microvascular disease (peripheral neuropathy,…”
Get full text

Diabetes and coronary risk equivalency – a population-based cohort study from Western Denmark by Olesen, K, Gyldenkerne, C G, Thrane, P G, Maeng, M M

“…Abstract Background Diabetes is associated with an increased risk of cardiovascular disease. Accordingly, guidelines recommend extensive management of…”
Get full text

Trends in mortality and ischemic outcomes in patients with ST-segment elevation myocardial infarction following implementation of a primary percutaneous coronary intervention strategy, 2003–2017 by Thrane, P, Olesen, K K W, Thim, T, Gyldenkerne, C, Kristensen, S D, Maeng, M

“…Abstract Introduction In Denmark, primary percutaneous coronary intervention (pPCI) has served as the national reperfusion strategy in ST-segment elevation…”
Get full text

Life expectancy in women and men after STEMI: a comparison to a matched general population by Thrane, P, Olesen, K K W, Gyldenkerne, C, Hansen, M K, Thim, T, Kristensen, S D, Maeng, M

“…Abstract Background/Introduction ST-elevation myocardial infarction (STEMI) is considered a risk factor for short- and long-term mortality. Further, studies…”
Get full text

Mortality related to left ventricular ejection fraction and obstructive coronary artery disease in non-ST-segment elevation myocardial infarction by Stoedkilde-Joergensen, N, Olesen, K K W, Gyldenkerne, C, Thrane, P G, Hansen, M K, Noergaard, B L, Nielsen, R R, Maeng, M

“…Abstract Background Extent of coronary artery disease (CAD) and the severity of reduced left ventricular ejection fraction (LVEF) have both been associated…”
Get full text

Symptomatic patients without coronary artery disease do not have excess cardiovascular risk compared to the general population by Olesen, K K W, Andersen, M H, Gyldenkerne, C, Hansen, M K, Stodkilde-Jorgensen, N, Thrane, P G, Norgaard, B L, Mortensen, M B, Maeng, M

“…Abstract Background Patients with stable angina with no coronary atherosclerosis by coronary computed tomography angiography (CCTA) have a lower cardiovascular…”
Get full text

Trends in major cardiac events after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention from 2003 to 2017: the western Denmark heart registry by Thrane, P, Olesen, K K W, Thim, T, Gyldenkerne, C, Hansen, M K, Stoedkilde-Joergensen, N, Kristensen, S D, Maeng, M

“…Abstract Background In Denmark, primary percutaneous coronary intervention (PCI) has been the national reperfusion strategy since 2003. We recently reported a…”
Get full text

Temporal trends in major bleeding after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction from 2003 to 2017: the Western Denmark Heart Registry by Thrane, P, Olesen, K K W, Thim, T, Gyldenkerne, C, Hansen, M K, Stoedkilde-Joergensen, N, Kristensen, S D, Maeng, M

“…Abstract Background Management of patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention…”
Get full text

Twenty-year trends in peripheral artery disease, lower extremity revascularization, and lower extremity amputation in newly diagnosed type 2 diabetes by Gyldenkerne, C, Olesen, K K W, Kahlert, J, Thrane, P G, Hansen, M K, Stoedkilde-Joergensen, N, Soerensen, H T, Thomsen, R W, Maeng, M

“…Abstract Background Trends in risk of lower extremity complications in patients with newly diagnosed type 2 diabetes (T2DM) are largely unexplored. Purpose To…”
Get full text

Composition of non-HDL cholesterol and residual cardiovascular risk in secondary prevention by Hansen, M K, Olesen, K K W, Thrane, P G, Gyldenkerne, C, Stoedkilde-Joergensen, N, Andersen, M H, Maeng, M, Mortensen, M B

“…Abstract Background Non-high-density lipoprotein cholesterol (non-HDL-C) is associated with atherosclerotic cardiovascular disease (ASCVD) and is a recommended…”
Get full text

Bleeding after percutaneous coronary intervention and selection of candidates for long-term dual antithrombotic treatment by Thrane, P, Olesen, K K W, Wurtz, M, Gyldenkerne, C, Mortensen, M B, Kristensen, S D, Maeng, M B

“…Abstract Background The European Society of Cardiology recommends addition of a second antithrombotic drug (a P2Y12 inhibitor or rivaroxaban 2.5 mg twice…”
Get full text

Ten-year cardiovascular risk in diabetes patients without of coronary artery disease – a Danish cohort study by Olesen, K.K.W, Madsen, M, Gyldenkerne, C, Thrane, P.G, Thim, T, Jensen, L.O, Botker, H.E, Sorensen, H.T, Maeng, M

“…Abstract Background Patients with diabetes without obstructive coronary artery disease (CAD) by coronary angiography (CAG) have a risk of myocardial infarction…”
Get full text